GLP-1 medications have changed a lot of conversations about weight and metabolic health, and if you're nursing, you've probably run into a frustrating wall: lots of strong opinions, very few actual numbers. You deserve the numbers. So here's what the lactation evidence currently shows — calmly, specifically, and without telling you what to do, because that part belongs to you and your provider.
A note before anything else: don't start, stop, or change a prescription based on a blog. Use this to walk into a better conversation with your clinician, not to make a unilateral decision.
Injectable semaglutide: the evidence is reassuring
For injectable semaglutide, the Drugs and Lactation Database (LactMed) summarizes data that should ease a lot of worry. In a study of eight nursing mothers, the drug was undetectable in breast milk (below 1.7 mcg/L). Even accounting for any trace amount, a baby's oral absorption would be only about 1% — semaglutide is a large protein-like molecule that doesn't cross into milk well and isn't readily absorbed from a baby's gut. And eight breastfed infants showed normal growth and development.
Putting it together, LactMed concludes that injectable semaglutide presents little risk to a nursing infant. That's about as encouraging as lactation data gets for a relatively newer medication.
The injectable-versus-oral distinction that matters
Here's a detail that's easy to miss and genuinely important: the form of the drug changes the picture. The reassuring data above are for the injectable form.
Some oral semaglutide brands contain an absorption enhancer called SNAC — a compound added precisely because it helps the drug cross membranes that it otherwise wouldn't. The concern is that SNAC may pass into milk. Because of this, the injectable form is generally preferred while breastfeeding. If you and your provider are discussing semaglutide during lactation, it's worth specifically asking about injectable versus oral, rather than treating "semaglutide" as one undifferentiated thing.
Tirzepatide: reassuring early data, used with caution
For tirzepatide, the LactMed entry reports similarly low transfer into milk. Tirzepatide was undetectable in 164 of 171 milk samples studied. In the handful of samples where it was detected, the amount was less than 0.02% of the mother's dose — a vanishingly small fraction — and, like semaglutide, it's a large molecule likely broken down in the baby's gut rather than absorbed into the bloodstream.
LactMed's bottom line is measured and worth quoting closely: tirzepatide is "not a reason to discontinue breastfeeding," but it should be used "with caution" — particularly while nursing a newborn or a preterm baby, whose immature gut and smaller size warrant extra care. The caution isn't a red flag so much as an acknowledgment that the youngest, most vulnerable babies deserve the most conservative read of limited data.
Why "decide with your provider" isn't a dodge
It would be easier to end with a clean yes or no. But the honest answer is that the data are still limited — these are real studies with real numbers, but small ones, and they can't anticipate every individual situation. The right decision depends on factors only you and your clinician can weigh together:
- Why you need the medication — the health benefit on your side of the scale
- Your baby's age and health — a thriving toddler and a preterm newborn are not the same calculation
- The most current evidence, which continues to evolve
That's not hedging. That's how good medical decisions actually get made — by putting your specifics next to the data, rather than applying a one-size-fits-all rule to a deeply individual choice.
Where this leaves you
If you've been quietly assuming that wanting a GLP-1 medication means you'd have to wean — or, conversely, that you should just take it and not think about the nursing part — neither of those is the message here. The current evidence for injectable semaglutide and for tirzepatide points to little risk to a nursing infant, with sensible caveats about oral formulations and very young babies. If you're navigating weaning more broadly for any reason, our guide to weaning from breastfeeding walks through doing it gently.
Wanting to care for your own health while you feed your baby isn't a conflict of interest — it's parenting. Take these numbers to your provider, ask your questions out loud, and make the call together. You're not being selfish for considering it, and you're not being reckless for asking.